RAND Europe sought to better understand how commissioners of healthcare services and Cancer Alliances make decisions about early diagnosis interventions at a local level, with a particular focus on England and Northern Ireland.
Successes in the early treatment of breast cancer are to be celebrated. But those achievements need not limit the development of further and better treatment for patients. Understanding the disease's wider effects could help bring this about.
The Vitality Age with pre-existing conditions (VAPC) is an extension to VA.3, allowing explicit differentiation between individuals with one or more selected pre-existing conditions that negatively affect their health and life expectancy.
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three interconnected phases. This is the summary report of the cross-analysis of data gathered through the three phases.
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three interconnected phases. The first phase was a mapping review on the published literature on the impacts of treatment of early breast cancer.
The economics of integrative oncology are problematic because of the lack of good studies, the lack of historic incentives for efficiency, and the high cost of cancer care and its financial toxicity on patients. However, these problems can be overcome, with help from one good economic evaluation at a time.
The purpose of this study is to extend the pilot study in a group-randomized controlled trial to test the effectiveness of tailored messaging delivered by Community Health Navigators to guide individuals from especially hard-to-reach, multicultural, and underinsured communities into primary care clinics for referral for CRC screening (Phase I) and to continue navigation after referral to track effects of the intervention on completion of CRC screening (Phase II).
RAND Europe conducted a study on the societal impact of early breast cancer, divided into three interconnected phases. The third phase was a qualitative study assessing the factors affecting access and delivery of treatment for early breast cancer.
RAND Europe conducted a study on the societal impact of early breast cancer. This study was divided into three connected phases. The second phase was a systematic review on non-clinical outcomes of recurrence after treatment of early breast cancer.
A study exploring the feasibility of introducing OBP for new cancer medicines in the NHS, focusing on the kinds of outcomes that patients and their carers consider most important to refer to in this context.
The National Institute for Occupational Safety and Health (NIOSH) asked the RAND Corporation to develop an approach for estimating the economic benefit of NIOSH research, using three case studies. A new report details findings and recommendations.
The National Cancer Institute's "Acupuncture for Cancer Symptom Management" symposium reviewed the evidence on acupuncture use for clinical oncology treatment; this paper provides a summary and recommendations for future research.